Tessa Therapeutics Competitors and Similar CompaniesClear all
Immatics's competitors and similar companies include Vericel.
 Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Vericel Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Cambridge, US HQ Ann Arbor, US |
Employees | Employees 29723% increase | Employees 24112% increase |
Valuation ($) | Valuation ($) 1.1 b | Valuation ($) 2.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) $276.3m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $70.7m (FY, 2025) |
Gross profit | Gross profit €53m (FY, 2025) | Gross profit $205.6m (FY, 2025) |
Net income | Net income (€196.4m) (FY, 2025) | Net income $16.5m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Vericel
HQ
Cambridge, US
Employees
241↑ 12% increase
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions.
View company